The thyroid medication levothyroxine may be associated with bone loss, according to a study that will be presented at the ...

The potential health benefits of GLP-1 diabetes and weight loss meds keep piling up: New research shows they may also shield ...

The potential health benefits of GLP-1 diabetes and weight loss meds keep piling up: New research shows they may also ...

Researchers said the drugs could make a major difference for chronic kidney disease patients by helping to reduce other risk ...

Diabetes and obesity drugs have been found to reduce the risk of kidney failure and protect cardiovascular health in people ...

“It is a progressive condition eventually leading to kidney failure requiring dialysis or ... including semaglutide (also known as Ozempic or Wegovy), dulaglutide (Trulicity) and liraglutide ...

The biggest and most comprehensive analysis of glucagon-like peptide-1 (GLP-1) receptor agonists on kidney and cardiovascular outcomes shows they have significant benefits in people with and without ...

Study finds yet another use for popular diabetes and obesity drugs - Several new uses have been found for the drugs ...

including semaglutide (also known as Ozempic or Wegovy), dulaglutide (Trulicity) and liraglutide (Victoza). The results showed that compared to placebo, GLP-1 receptor agonists reduced the risk of ...

A recent study showed that GLP-1 drugs which are beneficial for diabetes and weight loss can also protect your kidneys from ...

Giovanni E. Ferreira, University of Sydney and Christina Abdel Shaheed, University of Sydney The drug semaglutide, commonly ...